- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/21 - Radicals derived from sulfur analogues of carbonic acid
Patent holdings for IPC class C07D 295/21
Total number of patents in this class: 21
10-year publication summary
|
2
|
0
|
3
|
1
|
0
|
2
|
1
|
0
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3606 |
2 |
| Chinese PLA General Hospital | 38 |
2 |
| East China Normal University | 174 |
2 |
| Fudan University | 650 |
2 |
| Icahn School of Medicine at Mount Sinai | 910 |
2 |
| BioNTech SE | 598 |
2 |
| BASF SE | 20519 |
1 |
| Centre National de La Recherche Scientifique | 10158 |
1 |
| Beijing University of Chemical Technology | 303 |
1 |
| ICOS Corporation | 20 |
1 |
| Leo Laboratories Limited | 61 |
1 |
| PanThera Biopharma LLC | 3 |
1 |
| Peking University | 1252 |
1 |
| Universite de Poitiers | 187 |
1 |
| Tianjin Kaitai Biomed Technology Co., Ltd. | 1 |
1 |
| Other owners | 0 |